Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure

Saif S. Rathore, Jeptha P. Curtis, Yongfei Wang et al. · JAMA · 2003 · 769 citations

Medicine, Cardiology, Physiology +11

MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

S Teven M. H Affner, S Eppo L Ehto, T Apani R Önnemaa et al. · 1998 · 484 citations

Medicine, Cardiology, Internal Medicine +17

Effect of linagliptin monotherapy on glycaemic control and markers of <i>β</i> ‐cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

Stefano Del Prato, Anthony Barnett, Holger Huisman et al. · Diabetes Obesity and Metabolism · 2010 · 298 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of linagliptin as add‐on therapy to metformin in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled study

Marja‐Riitta Taskinen, Julio Rosenstock, Ilkka Tamminen et al. · Diabetes Obesity and Metabolism · 2010 · 293 citations

Medicine, Pharmacology, Pharmacotherapy +17